GSK taps Julie Brown as next CFO

Global drug company GSK named Julie Brown to replace Iain Mackay, who is retiring from the company, as its CFO, effective May 1, 2023. 

Advertisement
By: Paige Twenter

Ms. Brown is currently the COO and CFO of fashion company Burberry. She previously worked at AstraZeneca for 25 years.

Ms. Brown will join GSK in April 2023 and work with Mr. Mackay to help with the transition, the company said in a Sept. 26 news release.

HEDIS relief is possible — How health plans can finally take a breath

Recommended OnDemand Webinar

Advertisement

Next Up in Pharmacy

  • 75 drugs currently in shortage: FDA

    The number of active drug shortages has declined sharply since June, according to the FDA’s drug shortage database. Seventy-five drugs…

    By: Mackenzie Bean

  • 6 recent updates on GLP-1 drugs

    From payer shifts to regulatory milestones, GLP-1 therapies for obesity and diabetes continued to reshape the healthcare landscape in December.…

    By: Ella Jeffries

  • 73 drugs lost exclusivity in 2025

    In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval…

    By: Paige Twenter
Advertisement

Comments are closed.